NCT05800509 Gestational Diabetes and Perinatal Depression: an Intervention Program
| NCT ID | NCT05800509 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Gestational Diabetes Mellitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2023-10-26 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2023-10-26 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: The gestational diabetes mellitus and perinatal depression are both global public health issues with high prevalence. Non-perinatal diabetes mellitus and depression are confirmed to have reciprocal influence, which is bidirectional relationship. However, there are still no any confirmations of relationship in the perinatal period. The reason could be that these kinds of studies mostly had been done for postpartum depression, they had rarely been discussed with a clearly sequential influence between gestational diabetes mellitus and perinatal depression. Additionally, there have not been so many Asian countries which been done this kind of studies, therefore, this study will focus on the relationship of gestational diabetes mellitus and perinatal depression. Purpose: This study will discuss the bidirectional relationship of gestational diabetes mellitus and perinatal depression. In the other words, the prenatal depression influences on gestational diabetes mellitus, and vice versa. Those changeable factors, such as social support, health behavior, prenatal body index, weight gain during pregnancy, perinatal complications…etc, will be tested for whether they could be regulators or not between the gestational diabetes mellitus and perinatal depression.Afterwards, a part of participants with diagnosis of gestational diabetes mellitus will receive the intervention of health education to influence the health behavior, then depression and other obstetrics and gynecological results will be tested for effects.
Eligibility Criteria
Inclusion Criteria: * 1\. The diagnosis of gestational diabetes mellitus. * 2\. No any history of disease\* before the pregnancy or do have history of disease\* without taking any medicines. (\*disease, eg. hypertension, diabetes mellitus, hyperthyroidism...etc.) * 3\. No recurrent pregnancy loss and stable condition in the first trimester of pregnancy. * 4\. Using smart phone. * 5\. Being willing to participate in this study. Exclusion Criteria: \- 1. No diagnosis of diabetes mellitus before pregnancy.
Contact & Investigator
HUNG-HUI CHEN
PRINCIPAL INVESTIGATOR
National Taiwan University Hostiptal
Frequently Asked Questions
Who can join the NCT05800509 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Gestational Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05800509 currently recruiting?
Yes, NCT05800509 is actively recruiting participants. Contact the research team at hunghuichen@ntu.edu.tw for enrollment information.
Where is the NCT05800509 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05800509 clinical trial?
NCT05800509 is sponsored by National Taiwan University Hospital. The principal investigator is HUNG-HUI CHEN at National Taiwan University Hostiptal. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.